231 related articles for article (PubMed ID: 36340248)
1. Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in China: Results From the CHERRY Study.
Liu X; Shen P; Zhang D; Sun Y; Chen Y; Liang J; Wu J; Zhang J; Lu P; Lin H; Tang X; Gao P
JACC Asia; 2022 Feb; 2(1):33-43. PubMed ID: 36340248
[TBL] [Abstract][Full Text] [Related]
2. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
[TBL] [Abstract][Full Text] [Related]
3. Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study.
Tang X; Zhang D; He L; Wu N; Si Y; Cao Y; Huang S; Li N; Li J; Dou H; Gao P; Hu Y
Am Heart J; 2019 May; 211():34-44. PubMed ID: 30831332
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Three Atherosclerotic Cardiovascular Disease Risk Prediction Models in Individuals Aged 75 and Older.
Wang Z; Yang X; Li L; Zhang X; Zhou W; Chen S
Clin Interv Aging; 2024; 19():529-538. PubMed ID: 38525315
[TBL] [Abstract][Full Text] [Related]
5. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China.
Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S
BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590
[TBL] [Abstract][Full Text] [Related]
6. Comparing the performance of machine learning and conventional models for predicting atherosclerotic cardiovascular disease in a general Chinese population.
Fan Z; Du Z; Fu J; Zhou Y; Zhang P; Shi C; Sun Y
BMC Med Inform Decis Mak; 2023 Jul; 23(1):134. PubMed ID: 37488520
[TBL] [Abstract][Full Text] [Related]
7. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).
Yang X; Li J; Hu D; Chen J; Li Y; Huang J; Liu X; Liu F; Cao J; Shen C; Yu L; Lu F; Wu X; Zhao L; Wu X; Gu D
Circulation; 2016 Nov; 134(19):1430-1440. PubMed ID: 27682885
[TBL] [Abstract][Full Text] [Related]
8. Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes.
Liang J; Li Q; Fu Z; Liu X; Shen P; Sun Y; Zhang J; Lu P; Lin H; Tang X; Gao P
Eur J Prev Cardiol; 2023 Sep; 30(12):1293-1303. PubMed ID: 37315163
[TBL] [Abstract][Full Text] [Related]
9. [Accuracy of the China-PAR and WHO risk models in predicting the ten-year risks of cardiovascular disease in the Chinese population].
Chen WY; Liu XF; Shen P; Chen Q; Sun YX; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Aug; 43(8):1275-1281. PubMed ID: 35981990
[No Abstract] [Full Text] [Related]
10. [Application of the China-PAR stroke risk equations in a rural northern Chinese population].
Tang X; Zhang DD; Liu XF; Liu QP; Cao Y; Li N; Huang SP; Dou HD; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 52(3):444-450. PubMed ID: 32541976
[TBL] [Abstract][Full Text] [Related]
11. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.
Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK
Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769
[TBL] [Abstract][Full Text] [Related]
12. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records.
Rodriguez F; Chung S; Blum MR; Coulet A; Basu S; Palaniappan LP
J Am Heart Assoc; 2019 Jul; 8(14):e011874. PubMed ID: 31291803
[TBL] [Abstract][Full Text] [Related]
14. Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
Medina-Inojosa JR; Somers VK; Garcia M; Thomas RJ; Allison T; Chaudry R; Wood-Wentz CM; Bailey KR; Mulvagh SL; Lopez-Jimenez F
J Am Coll Cardiol; 2023 Oct; 82(15):1499-1508. PubMed ID: 37793746
[TBL] [Abstract][Full Text] [Related]
15. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index.
Khera R; Pandey A; Ayers CR; Carnethon MR; Greenland P; Ndumele CE; Nambi V; Seliger SL; Chaves PHM; Safford MM; Cushman M; Xanthakis V; Vasan RS; Mentz RJ; Correa A; Lloyd-Jones DM; Berry JD; de Lemos JA; Neeland IJ
JAMA Netw Open; 2020 Oct; 3(10):e2023242. PubMed ID: 33119108
[TBL] [Abstract][Full Text] [Related]
16. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
[TBL] [Abstract][Full Text] [Related]
17. Performance of the American Heart Association/American College of Cardiology Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Self-reported Physical Activity Levels.
Pandey A; Mehta A; Paluch A; Ning H; Carnethon MR; Allen NB; Michos ED; Berry JD; Lloyd-Jones DM; Wilkins JT
JAMA Cardiol; 2021 Jun; 6(6):690-696. PubMed ID: 33909016
[TBL] [Abstract][Full Text] [Related]
18. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
19. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease.
Jung KJ; Jang Y; Oh DJ; Oh BH; Lee SH; Park SW; Seung KB; Kim HK; Yun YD; Choi SH; Sung J; Lee TY; Kim SH; Koh SB; Kim MC; Chang Kim H; Kimm H; Nam C; Park S; Jee SH
Atherosclerosis; 2015 Sep; 242(1):367-75. PubMed ID: 26255683
[TBL] [Abstract][Full Text] [Related]
20. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
Mortensen MB; Nordestgaard BG; Afzal S; Falk E
Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
